栾一,李伟,吴立荣,刘兴德,李屏,梁金峰,韦波,沈正,谢登海,李安敏,陈云,熊国宝,伍洪令,李董江,段宗刚

• 1:贵州医科大学附属医院心血管内科

摘要(Abstract)：

目的探讨合并糖尿病的急性ST段抬高型心肌梗死(ST-segment elevation myocardial inf arction,STEMI)患者的临床特征,分析行直接经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后12个月内的预后情况。方法按标准入选的375例STEMI患者分为两组,合并糖尿病的STEMI患者140例作为糖尿病组,血糖正常的STEMI患者235例作为血糖正常组。分别对两组患者的临床资料、冠状动脉病变特征、置入支架类型、术后慢血流/无复流发生率、住院期间死亡率、术后12个月内的预后情况进行比较。结果糖尿病组患者年龄[(63.0±12.5)岁比(58.1±13.6)岁,P=0.001]、高血压病(59.3%比37.9%,P<0.001)、高脂血症(53.6%比37.4%,P=0.002)、入院时Killip心功能分级≥Ⅲ级(9.3%比3.8%,P=0.030)比例均高于血糖正常组,差异均有统计学意义;糖尿病组患者吸烟率(55.0%比72.8%,P<0.001)低于血糖正常组,差异有统计学意义;糖尿病组患者三支血管病变(40.7%比28.9%,P=0.019)、合并左主干病变(13.6%比7.2%,P=0.044)比例及术后慢血流/无复流(12.9%比5.5%,P=0.013)发生率高于血糖正常组,差异均有统计学意义;单支血管病变(27.9%比44.7%,P=0.001)比率低于血糖正常组,差异有统计学意义。糖尿病组患者住院期间的死亡率(6.4%比1.7%,P=0.020)、术后12个月内再次血运重建(7.9%比0.9%,P=0.001)及心力衰竭(7.9%比2.6%,P=0.017)发生率均高于血糖正常组,差异均有统计学意义。结论合并糖尿病的STEMI患者平均年龄较大,入院时Killip心功能分级≥Ⅲ级的比率较高,高血压病、高脂血症、三支血管病变、左主干病变发生率较高,住院期间死亡率较高,术后随访期内心源性死亡率及再发心肌梗死发生率未见明显升高,此类患者可能从早期介入治疗中获益更大。

关键词(KeyWords)： 糖尿病;急性ST段抬高型心肌梗死;预后

Abstract:

Keywords:

基金项目(Foundation): 贵阳市科技平台建设项目(GY2017-34)

作者(Author): 栾一,李伟,吴立荣,刘兴德,李屏,梁金峰,韦波,沈正,谢登海,李安敏,陈云,熊国宝,伍洪令,李董江,段宗刚

参考文献(References)：

• [1]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要.中国循环杂志,2018,33(1):1-8.
• [2]赵良平,刘海峰.糖尿病//霍勇,王伟民,高炜(主译).介入心脏病学.5版.北京:北京大学医学出版社,2010:25-53.
• [3]Roff M,Moliterno DJ,Meier B,et al.Impact of different platelet glycoprotein IIb/Ⅲa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention:TARGET 1-year follow-up.Circulation,2002,105(23):2730-2736.
• [4]Brogan GX,Peterson ED,Mulgund J,et al.Treatment disparitles in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.Dlabetes Care,2006,29(1):9-14.
• [5]Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15(7):539-553.
• [6]American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care,2014,37(Suppl 1):S81-S90.
• [7]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2015,43(5):380-393.
• [8]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013).中华糖尿病杂志,2014,6(7):447-498.
• [9]高晓津,杨进刚,杨跃进,等.中国急性心肌梗死患者心血管危险因素分析.中国循环杂志,2015,30(3):206-210.
• [10]America Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care,2010,33(Suppl 1):S204-209.
• [11]刘洋,刘恒亮,耿国英,等.急诊PCI对糖尿病急性心肌梗死患者预后影响的研究.中国心血管病研究,2013,11(8):577-581.
• [12]Norhammar A,Mellbin L,Cosentino F.Diabetes:Prevalence,prognosis and management of a potent cardiovascular risk factor.Eur J Prev Cardiol,2017,(3 suppl):52-60.
• [13]Bragg F,Holmes MV,Iona A,et al.Association between diabetes and cause-specific mortality in rural and urban areas of China.J AMA,2017,317(3):280-289.
• [14]Kosiborod M,Rathore SS,Inzucchi SE,et al.Admission glucose and mortality in elder patients hospitalized with acute myocardilial inffarction:Implications for patients with and without recognized diabetes.Circulation,2005,111(23):3078-3086.
• [15]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016).中华心血管病杂志,2016,44(5):382-400.
• [16]Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J,2018,39(2):119-177.
• [17]徐靖,程澜.经皮冠状动脉介入治疗急性ST段抬高心肌梗死患者血管再通过程中发生心室颤动的相关危险因素分析.中国介入心脏病学杂志,2016,24(5):247-250.
• [18]Ryden L,Grant PJ,Anker SD,et al.ESC Guidelines on diabetes,pre-diabetes,and cardiovascular diseases developed in collaboration with the EASD:The Task Force on diabetes,prediabetes,and cardiovascular diseases of the European Society of Cardiology(ESC)and developed in collaboration with the European Association for the Study of Diabetes(EASD).Eur Heart J,2013,34(39):3035–3087.
• [19]Ritsinger V,Saleh N,Lagerqvist B,et al.Results from the Swedish Coronary Angiography and Angioplasty Registry(SCAAR).Circ Cardiovasc Interv,2015,8(6):e002328.